Phase II trial of sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer (SCLC): Final results. This is an ASCO Meeting Abstract from the 2012 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results